MRK: FDA Approves KEYTRUDA
MRK's KEYTRUDA and KEYTRUDA QLEX are approved by the FDA for first-line treatment of PD-L1+ advanced triple-negative breast cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.